- Home
- TOI
as 11-14-2024 10:36am EST
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services.
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | CERRITOS |
| Market Cap: | 20.1M | IPO Year: | N/A |
| Target Price: | $2.50 | AVG Volume (30 days): | 187.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.79 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.23 - $2.50 | Next Earning Date: | 11-13-2024 |
| Revenue: | $361,067,000 | Revenue Growth: | 23.31% |
| Revenue Growth (this year): | 29.17% | Revenue Growth (next year): | 16.43% |
Latest The Oncology Institute Inc. News
TOI Breaking Stock News: Dive into TOI Ticker-Specific Updates for Smart Investing
GlobeNewswire
a day ago
The Oncology Institute Reports Third Quarter 2024 Financial Results
GlobeNewswire
4 days ago
The Oncology Institute Announces Certification to Administer Pluvicto Therapy in California
GlobeNewswire
10 days ago
The Oncology Institute Announces Third Quarter 2024 Earnings Release Date and Conference Call
GlobeNewswire
23 days ago
The Oncology Institute Joins Lantern’s Cancer Care Network of Excellence
GlobeNewswire
a month ago
The American Journal of Managed Care® and The Oncology Institute to Co-Host Symposium for Value-Based Cancer Care
GlobeNewswire
2 months ago
The Oncology Institute of Hope & Innovation Launches Oregon Market
GlobeNewswire
2 months ago
The Oncology Institute Announces CFO Transition
GlobeNewswire
3 months ago
The Oncology Institute Reports Second Quarter 2024 Financial Results and Updates Full Year 2024 Guidance
Compare TOI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TOI The Oncology Institute Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.